NNSA Awards $10M to SHINE for Medical Isotope Production

The Department of Energy’s semiautonomous National Nuclear Security Administration has awarded $10 million in Phase II funding to SHINE Medical Technologies as part of the agency’s program to promote a domestic supply of molybdenum-99 (mo-99).
The…

In This Issue

More on This Topic